- Home
- QXO vs SNN Comparison
QXO vs SNN Comparison
Compare QXO & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QXO | SNN |
|---|---|---|
| Founded | 1988 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | EDP Services | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2B | 14.0B |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | QXO | SNN |
|---|---|---|
| Price | $20.93 | $33.44 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 4 |
| Target Price | ★ $33.45 | $32.83 |
| AVG Volume (30 Days) | ★ 7.1M | 476.9K |
| Earning Date | 11-06-2025 | 03-02-2026 |
| Dividend Yield | N/A | ★ 2.19% |
| EPS Growth | N/A | ★ 59.91 |
| EPS | N/A | ★ 0.56 |
| Revenue | $4,662,873,000.00 | ★ $5,944,000,000.00 |
| Revenue This Year | $12,120.21 | $7.78 |
| Revenue Next Year | $61.96 | $5.13 |
| P/E Ratio | ★ N/A | $29.10 |
| Revenue Growth | ★ 8107.98 | 5.35 |
| 52 Week Low | $11.85 | $23.69 |
| 52 Week High | $24.69 | $38.79 |
Technical Indicators
Market Signals| Indicator | QXO | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 67.54 | 48.01 |
| Support Level | $15.99 | $32.68 |
| Resistance Level | $17.53 | $33.56 |
| Average True Range (ATR) | 0.86 | 0.41 |
| MACD | 0.47 | 0.14 |
| Stochastic Oscillator | 95.67 | 78.51 |
Price Performance
Historical ComparisonAbout QXO QXO Inc. Common Stock
QXO Inc is a building products distribution company engaged in the distribution of roofing, waterproofing and complementary building products in North America. It offers a full suite of business applications, including ERP, warehouse management, accounting, CRM, and business intelligence solutions.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.